Subscribe to the SLI Medical mailing list to receive updates on new arrivals, special offers and our promotions.
The store will not work correctly in the case when cookies are disabled.
Get Up to 25% OFF PPE MasksGowns * Limited time only.
SLI MEDICAL IS A WHOLESALE SITE! WE ONLY SELL TO QUALIFIED FACILITIES (Such As Hospitals, Physician Offices, & Distributors). All Addresses are Verified.
SLI Medical Acceptable Dating: we will ship >= 90 days
Sample Type
Human Serum / Plasma Sample
Storage Requirements
Requires Refrigeration
Test Method
Chemiluminescent Microparticle Immunoassay (CMIA)
Test Name
CA 19-9XR
Test Type
Cancer
UNSPSC Code
41116010
Volume
R1: 6.6 mL
R2: 5.9 mL
Features
ARCHITECT CA 19-9XR assay is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of 1116-NS-19-9 reactive determinants in human serum or plasma on the ARCHITECT iSystem
To be used as an aid in the management of pancreatic cancer patients with detectable levels of CA 19-9 at some point in their disease process and in conjunction with other clinical methods